Haematology: How far we've come, and how far we have to go

Sponsored Content

In a Special Report, Patrick Laroche, Janssen EMEA Haematology Therapy Area Lead, looks at how haematology is leading the way in oncology innovation, how CAR-T has the potential to revolutionise treatment for multiple myeloma, and the challenges that lie ahead in this field.

Over the last decade, treatment for blood cancers has changed significantly, transforming expectations of what a diagnosis means for patients. A new decade is now beginning, and I believe we are sitting at a truly exciting moment of exponential scientific development in cancer specifically.